Groupe Bruxelles Lambert Invests $62.16 Billion in Concentrix Corporation $CNXC

Groupe Bruxelles Lambert acquired a new stake in Concentrix Corporation (NASDAQ:CNXCFree Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 2,773,667 shares of the company’s stock, valued at approximately $62,157,877,000. Concentrix makes up 100.0% of Groupe Bruxelles Lambert’s portfolio, making the stock its biggest holding. Groupe Bruxelles Lambert owned 4.55% of Concentrix at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. AQR Capital Management LLC grew its holdings in Concentrix by 1.8% in the third quarter. AQR Capital Management LLC now owns 4,380,821 shares of the company’s stock worth $202,175,000 after purchasing an additional 75,352 shares during the period. Dimensional Fund Advisors LP raised its holdings in shares of Concentrix by 18.5% during the first quarter. Dimensional Fund Advisors LP now owns 2,951,378 shares of the company’s stock valued at $80,746,000 after purchasing an additional 460,108 shares during the period. Pzena Investment Management LLC raised its holdings in shares of Concentrix by 0.5% during the first quarter. Pzena Investment Management LLC now owns 2,943,212 shares of the company’s stock valued at $80,526,000 after purchasing an additional 16,016 shares during the period. Kopernik Global Investors LLC bought a new position in shares of Concentrix during the 1st quarter worth about $44,523,000. Finally, State Street Corp boosted its position in shares of Concentrix by 8.7% during the 2nd quarter. State Street Corp now owns 1,622,854 shares of the company’s stock worth $85,776,000 after purchasing an additional 130,529 shares in the last quarter. Institutional investors and hedge funds own 90.34% of the company’s stock.

Analyst Ratings Changes

CNXC has been the subject of several research reports. Bank of America reduced their target price on Concentrix from $32.00 to $26.00 and set a “neutral” rating for the company in a research note on Tuesday, June 30th. Zacks Research lowered Concentrix from a “hold” rating to a “strong sell” rating in a report on Thursday, July 2nd. Barrington Research cut their price target on Concentrix from $38.00 to $30.00 and set an “outperform” rating on the stock in a report on Tuesday, June 30th. Robert W. Baird reduced their price objective on Concentrix from $40.00 to $30.00 and set an “outperform” rating for the company in a research note on Tuesday, June 30th. Finally, Canaccord Genuity Group decreased their price objective on Concentrix from $55.00 to $45.00 and set a “buy” rating for the company in a report on Tuesday, June 30th. Three investment analysts have rated the stock with a Buy rating, one has given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $32.75.

Get Our Latest Analysis on CNXC

Concentrix Price Performance

Concentrix stock opened at $24.49 on Monday. The firm has a market capitalization of $1.49 billion, a price-to-earnings ratio of -1.15, a price-to-earnings-growth ratio of 0.45 and a beta of 0.45. The firm’s fifty day moving average price is $24.61 and its two-hundred day moving average price is $27.94. Concentrix Corporation has a 1-year low of $19.12 and a 1-year high of $57.88. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 1.46.

Concentrix (NASDAQ:CNXCGet Free Report) last posted its earnings results on Monday, June 29th. The company reported $2.63 earnings per share for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.01). The business had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.47 billion. Concentrix had a positive return on equity of 19.82% and a negative net margin of 13.16%.The company’s revenue was up 1.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.70 EPS. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. On average, equities research analysts predict that Concentrix Corporation will post 9.67 earnings per share for the current fiscal year.

Concentrix Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, August 4th. Stockholders of record on Friday, July 24th were issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 5.9%. The ex-dividend date was Friday, July 24th. Concentrix’s dividend payout ratio (DPR) is currently -6.75%.

Concentrix Profile

(Free Report)

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.

See Also

Institutional Ownership by Quarter for Concentrix (NASDAQ:CNXC)

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.